IP Verse

Tcr Libraries - EP3116901

The patent EP3116901 was granted to Adaptimmune on Jun 12, 2019. The application was originally filed on Mar 13, 2015 under application number EP15709505A. The patent is currently recorded with a legal status of "Revoked".

EP3116901

ADAPTIMMUNE
Application Number
EP15709505A
Filing Date
Mar 13, 2015
Status
Revoked
Nov 16, 2024
Grant Date
Jun 12, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MICHALSKI HUTTERMANN & PARTNER PATENTANWALTE MBBMar 11, 2020-ADMISSIBLE

Patent Citations (11) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTWO2005116074
OPPOSITIONEP3350360
OPPOSITIONUS2009054257
OPPOSITIONUS2010047220
OPPOSITIONUS2010113300
OPPOSITIONUS2010297093
OPPOSITIONWO2004044004
OPPOSITIONWO2005116074
OTHERUS2010113300
OTHERUS2014371085
OTHERWO2005116074

Non-Patent Literature (NPL) Citations (6) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
EXAMINATION- DUNN STEVEN M ET AL, "Directed evolution of human T cell receptor CDR2 residues by phage display dramatically enhances affinity for cognate peptide-MHC without increasing apparent cross-reactivity", PROTEIN SCIENCE, WILEY, US, (20060401), vol. 15, no. 4, doi:10.1110/PS.051936406, ISSN 0961-8368, pages 710 - 721, XP002465974
OPPOSITION- BUONPANE et al., "Characterization of T Cell Receptors Engineered for High Affinity Against Toxic Shock Syndrome Toxin-1", JMB, (20051021), vol. 353, no. 2, pages 308 - 321, XP005086536
OPPOSITION- WEIDANZ et al., "Display of functional αβ single-chain T-cell receptor molecules on the surface of bacteriophage", J Immunol Methods, (19981201), vol. 221, no. 1-2, pages 59 - 76, XP004153560
OPPOSITION- HELMUT et al., "Changing T cell specificity by retroviral T cell receptor display", PNAS, (20001219), vol. 97, no. 26, pages 14578 - 14583, XP002169376
OPPOSITION- AGGEN et al., "Identification and engineering of human variable regions that allow expression of stable single-chain T cell receptors", Protein Engineering, Design & Selection, (20101214), vol. 24, no. 4, pages 361 - 372, XP055502562
OPPOSITION- DUNN, S. M. et al., "Directed evolution of human T cell receptor CDR2 residues by phage display dramatically enhances affinity for cognate peptide-MHC without increasing apparent cross-reactivity", Protein Science, (20060401), vol. 15, no. 4, pages 710 - 721, XP002465974

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents